Videos

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains what antibiotic stewardship is and what ideal antibiotic stewardship programs in hospitals look like.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, warns of the potential downsides to taking antibiotics.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, explains how antibiotics can be harmful if they are not used appropriately.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, compares antibiotic prescribing data in the United States to data in Europe.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses how antibiotic prescribing data vary across the United States.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, talks about the importance of educating patients on antibiotic use.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic prescribing data, with an emphasis on outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses “Get Smart About Antibiotics Week” and partnerships with international organizations.

Marcos Pires, PhD, assistant professor at Lehigh University, discusses the threat of antibiotic resistance.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains how his team identified national projections of drug-resistant pathogens.

Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains why Legionella is such a challenging pathogen.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, explains that adult patients with comorbidities should be vaccinated for pneumococcal disease.

Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains the current Legionella situation.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses programs to improve pneumococcal vaccination rates in veterans.

Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, explains her recent research on influenza antiviral treatment prescribing practices in 60 outpatient settings across the United States.

Marcos Pires, PhD, assistant professor at Lehigh University, explains whether or not his team’s strategy to use immunotherapy as a substitute for antibiotics will vary from patient to patient.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, University of Minnesota, discusses how restricting use of vancomycin impacted the emergence of vancomycin-resistant enterococci.

Megan Luther, PharmD, Advanced Health Services research fellow, Providence Veterans Affairs Medical Center, University of Rhode Island, College of Pharmacy, discusses a meta-analysis that examines the combination therapy of vancomycin and piperacillin/tazobactam causing acute kidney injuries.

Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses his research on 30-day mortality in adults with pneumococcal disease.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, explains his team’s unique approach to understanding multidrug-resistant infections.

Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, explains how antiviral flu treatments may be affecting patients in the outpatient setting.

Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections in the United States.

Holly Frost, MD, pediatrics physician scientist at the Marshfield Clinic Research Foundation, in Minocqua, Wisconsin, explains what Powassan virus is.

Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, at the University of Minnesota, discusses the growing problem of antibiotic-resistance in hospital-acquired infections.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses the prevalence of Zika virus infections in New York City.

Madeline King, PharmD, assistant professor of Clinical Pharmacy at the University of the Sciences, Philadelphia College of Pharmacy in Philadelphia, Pennsylvania, discusses ceftazidime-avibactam and its uses.

Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.

Rita Olans, DNP, CPNP-PC, APRN-BC, assistant professor at MGH Institute of Health Professions, discusses the importance of incorporating staff nurses in a healthcare setting's antimicrobial stewardship program.

Vikas Gupta, PharmD, BCPS, director of Clinical Strategy at Becton Dickinson, discusses his research on the national prevalence of multidrug-resistant organisms.

Marcos Pires, PhD, assistant professor at Lehigh University, explains the inspiration behind his team’s research in immunotherapy as a new way to fight bacterial infection.